Legal Representation
Attorney
Rosemary S. Tarlton
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 8, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 8, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 6, 2007 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 6, 2007 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 5, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 14, 2006 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Mar 28, 2006 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Feb 28, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 8, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Feb 7, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 17, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jan 13, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 9, 2006 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Jan 6, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 6, 2006 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 3, 2006 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Dec 19, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 19, 2005 | I | PAPER RECEIVED | Loading... | |
| Jun 20, 2005 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jun 20, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 16, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 18, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biological chemical diagnostic test kits for clinical or medical laboratory use, namely, for use in analysis of gene expression, genetics, single nucleotide polymorphism, haplotypes, proteins, and biological samples, for use in detecting diseases, for use in determining the progression of diseases, and for use in determining drug responses; diagnostic medical reagents, chemicals and solid matrix materials for biological, clinical or medical laboratory use for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, developmental disorders and cancer
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical diagnostic services, namely gene expression testing to determine immune response
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
044